These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39105195)

  • 1. A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus.
    Sha Y; Huang B; Hua C; Zhu Y; Tai W; Sun J; Li Y; Xia A; Wang Q; Lu L; Tan W; Jiang S
    MedComm (2020); 2024 Aug; 5(8):e677. PubMed ID: 39105195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell.
    Hua C; Zhu Y; Wu C; Si L; Wang Q; Sui L; Jiang S
    Front Microbiol; 2019; 10():2188. PubMed ID: 31611852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
    Kokuba H; Aurelian L; Neurath AR
    Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks.
    Fu Y; Li P; Xu W; Liu Z; Wang C; Wang Q; Tang J; Li W; Lu L; Jiang S
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
    Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
    BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.
    Neurath AR; Strick N; Li YY
    Antivir Chem Chemother; 1998 Mar; 9(2):177-84. PubMed ID: 9875389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
    Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K
    Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.
    Neurath AR; Jiang S; Strick N; Lin K; Li YY; Debnath AK
    Nat Med; 1996 Feb; 2(2):230-4. PubMed ID: 8574970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus.
    Li M; Ren Z; Wang Y; Jiang Y; Yang M; Li D; Chen J; Liang Z; Lin Y; Zeng Z; Xu R; Wang Y; Zhu L; Xiao W; Wu Q; Zhang B; Wan C; Yang Y; Wu B; Peng J; Zhao W; Shen C
    Emerg Microbes Infect; 2023 Dec; 12(2):2223669. PubMed ID: 37288876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivirals against monkeypox infections.
    Chiem K; Nogales A; Lorenzo M; Vasquez DM; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Mart Nez-Sobrido L
    bioRxiv; 2023 Apr; ():. PubMed ID: 37131608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population.
    Li M; Guo Y; Deng Y; Gao W; Huang B; Yao W; Zhao Y; Zhang Q; Huang M; Liu M; Li L; Guo P; Tian J; Wang X; Lin Y; Gan J; Guo Y; Hu Y; Zhang J; Yang X; Shang B; Yang M; Han Y; Wang Y; Cong P; Li M; Chu Q; Zhang D; Wang Q; Zhang T; Wu G; Tan W; Gao GF; Liu J
    Cell Rep; 2024 Jan; 43(1):113609. PubMed ID: 38159277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
    Freyn AW; Atyeo C; Earl PL; Americo JL; Chuang GY; Natarajan H; Frey TR; Gall JG; Moliva JI; Hunegnaw R; Asthagiri Arunkumar G; Ogega CO; Nasir A; Santos G; Levin RH; Meni A; Jorquera PA; Bennett H; Johnson JA; Durney MA; Stewart-Jones G; Hooper JW; Colpitts TM; Alter G; Sullivan NJ; Carfi A; Moss B
    Sci Transl Med; 2023 Oct; 15(716):eadg3540. PubMed ID: 37792954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential therapeutic targets for Mpox: the evidence to date.
    Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
    Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2022 Monkeypox outbreak: How the medicinal chemistry could help us?
    Silva-Júnior EFD
    Bioorg Med Chem; 2022 Nov; 73():117036. PubMed ID: 36183614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox.
    Peruzzu D; Fecchi K; Venturi G; Gagliardi MC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts.
    Dsouza L; Pant A; Offei S; Priyamvada L; Pope B; Satheshkumar PS; Wang Z; Yang Z
    Antiviral Res; 2023 Aug; 216():105651. PubMed ID: 37270160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development.
    Andrei G; Snoeck R
    Trends Pharmacol Sci; 2023 Oct; 44(10):719-739. PubMed ID: 37673695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.
    Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A
    Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.